Stock Expert AI
Accenture plc
ACN - NYSE - $136.96 ▼ -%0.28
-
Earnings Thu 24 Sep

Accenture opens the
books on Thursday evening.

17 analysts' median target is $195[FMP target], stock is $137, +42.4% upside potential. After Q3 +2.7% EPS beat[FMP earnings], the stock moved -2.5%.

summary below
Quick Take - in 40 seconds
A
BUY Council 4/6 - Moonshot 43

A = MoonshotScore 43[multi-pillar formula] + Council 4/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q1 consensus: revenue $18.1B[FMP est], EPS $3.21[FMP est]. 8 consecutive quarters of beat[FMP earnings].

$3.21 EPS Estimate Last year $3.94 - +6% YoY YoY
8 Beat Streak Expectations beaten consecutively for the last 8 quarters

Q3 EPS +2.7% beat[FMP] but the stock -2.5% D+1[FMP D+1]. Angie Park promised $186.2M CapEx + a sequential decline in Q1 during the Q3 earnings call[Angie Park capex transcript].

Watchlist

6 metrics stand out this quarter.

$3.2 billion Risk Indicator

Operating Margin Expansion

operating_margin_expansion

Accenture achieved a 17% operating margin in Q3, a 20 basis point increase year-over-year, and now expects its full fiscal year 2026 adjusted operating margin to be 15.8%, representing a 20 basis point expansion over fiscal 2025.

"Operating income was $3.2 billion in the third quarter, reflecting a 17% operating margin, a 20 basis point increase from operating margin in Q3 last year. For adjusted operating margin, we now expect fiscal year 2026 to be 15.8%, a 20 basis point expansion over adjusted fiscal 2025 results."

- Angie Park, Chief Financial Officer - Q3 FY26 Earnings Call - June 18, 2026
2026 Expectation / Guide

Fy26 Revenue Guidance

fy26_revenue_guidance

Accenture updated its full fiscal year 2026 revenue guidance to a range of 3%-4% growth in local currency over fiscal 2025, including an estimated 1% impact from its federal business and an inorganic contribution of about 1.5%.

"For the full fiscal 2026, we now expect our revenue to be in the range of 3%-4% growth in local currency over fiscal 2025, including an estimated 1% impact from our federal business. We continue to expect an inorganic contribution of about 1.5%."

- Angie Park, Chief Financial Officer - Q3 FY26 Earnings Call - June 18, 2026
100 Investor Focus

Ai Adoption Ecosystem

ai_adoption_ecosystem

Accenture is seeing increased client adoption of advanced AI projects, with another 100 clients initiating such projects this quarter, and is on track to more than double bookings from key emerging AI and data partners like Anthropic, Databricks, Gemini, Mistral AI, Nvidia, OpenAI, Palantir, and Snowflake.

"This quarter, we saw another 100 clients initiate advanced AI projects with us. We are also on track to more than double our bookings from our key emerging AI and data partners compared with FY 2025, including Anthropic, Databricks, Gemini, Mistral AI, Nvidia, OpenAI, Palantir, and Snowflake."

- Julie Sweet, Chair and Chief Executive Officer - Q3 FY26 Earnings Call - June 18, 2026
$300 million Investor Focus

Accenture Edge Midmarket

accenture_edge_midmarket

Accenture is launching 'Accenture Edge' to target the $240 billion mid-market segment, offering tailored business solutions for companies with $300 million to $3 billion in revenue.

"We estimate that the mid-market, which we look at as companies with between $300 million and $3 billion of revenue, is a $240 billion addressable market for us, growing high single digits. That is why we are launching a new business next week called Accenture Edge."

- Julie Sweet, Chair and Chief Executive Officer - Q3 FY26 Earnings Call - June 18, 2026
$100 million Investor Focus

Middle East Conflict Impact

middle_east_conflict_impact

The Middle East conflict negatively impacted Q3 revenue by approximately $100 million and is expected to have further indirect effects in Q4, particularly in discretionary spend.

"First, we were impacted by the conflict in the Middle East. We saw a revenue impact of approximately $100 million compared to our expectations, which was all consulting type of work, split evenly between the direct impact on our Middle East business and indirect effects outside of the region. In the last few weeks of the quarter, we saw this indirect impact globally in products and to a lesser degree in resources, mostly in discretionary spend."

- Julie Sweet, Chair and Chief Executive Officer - Q3 FY26 Earnings Call - June 18, 2026
$9 billion Investor Focus

Ot Security Acquisitions

ot_security_acquisitions

Accenture is investing approximately $9 billion in acquisitions this fiscal year, notably acquiring majority stakes in Dragos, runZero, and NetRise to create a first-of-its-kind OT security platform, significantly expanding its total addressable market.

"On acquisitions, because of the exciting OT cybersecurity acquisitions we announced today, which I'll talk about in a moment, we now expect to deploy approximately $9 billion of capital this year based on the anticipated closing dates of the acquisitions. This morning, we announced that we are acquiring a majority stake in Dragos, a leading platform for operational technology or OT, cybersecurity, and all of runZero, a leading vulnerability and exposure assessment firm, and NetRise, a leader in device security. Together, these acquisitions will create a first of a kind OT security platform that lets clients see threats, find vulnerabilities, and fix them before it becomes a crisis."

- Julie Sweet, Chair and Chief Executive Officer - Q3 FY26 Earnings Call - June 18, 2026

Stock Expert AI - Methodology

Do our scoring pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 4 / 6 Bullish

6 investor frameworks. 4 bullish (Ray Dalio, Klarman, Buffett, Munger), 1 bearish (Ken Griffin), 1 neutral (Jim Simons).

How is it calculated? ->
Ray Dalio macro - target upside +42.4%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 39
Klarman value - target upside +42.4%
Buffett quality - ROE score 5/5
Munger valuation - target upside +42.4%
Munger's Mindset character & balance sheet lens
Undervalued

Quality business, discounted price.

How is it calculated? ->
Financial HealthStrong
Margin of SafetyStrong
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
39.1 RSI 39.1 weak momentum, 50d below
MACD
-17.20 price below 50d - resistance dominant
50d MA
$165 stock 17.2% below - short-term resistance
200d MA
$220 stock 37.8% below - long-term pressure
Volume (10d)
-58% decrease - low participation
Resistance
$195
Analyst median target - upgrade trigger if broken
Current
$137
Pre-earnings position
Support
$187
Invalidation - close below this is a technical breakdown
Pattern
Range
$187-$195 band - earnings breakout/breakdown trigger

Past Performance

Accenture beat expectations in the last 8 quarters.

BEAT
Q4 FY25
$3.03 vs $2.98 est - +2.8%
BEAT
Q1 FY26
$3.94 vs $3.74 est - +0.8%
BEAT
Q2 FY26
$2.93 vs $2.86 est - -1.7%
BEAT
Q3 FY26
$3.80 vs $3.70 est - -2.5%

Q3 (June 18, 2026): EPS $3.80 vs $3.70 est[FMP], +2.7% beat. D+1 movement: -2.5%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $3.11 (no guidance)

Q3: EPS $3.80 vs $3.70 beat[FMP], stock -2.5% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q3 earnings call.

CapEx shock

Q3 CapEx $186.2M[FMP cashflow]. Q3 op margin 17.0%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $3.21 + CapEx discipline
Threshold: EPS > $3.21[FMP est].
Target: Break above median target $195[FMP target]; high target $282[FMP] upper bound.
Scenario B - In-Line
EPS approx $3.21 + CapEx < $186.2M
Threshold: EPS approx $3.21[FMP est], Q1 CapEx < $186.2M[FMP].
Target: Consolidation in the band between current $137[FMP] and median $195[FMP].
Scenario C - Miss
EPS < $3.11 or CapEx >= $186.2M
Threshold: EPS < $3.11[FMP estx0.97].
Target: Current $137 below SMA200 $220[FMP], if rejection continues, $187[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 17 analysts say?

Wall Street Consensus
$195
12-month median target price (+42.4% upside potential)
14
BUY
13
HOLD
0
SELL
Risk Management
$187
Invalidation level - critical support threshold
$165 - 50-day MA (below, -17.2%)
$220 - 200-day MA (below, -37.8%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - ACN Q1 FY27
A

You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Thursday evening. The framework is ready on this page: Q1 EPS threshold $3.21[FMP], CapEx threshold "below $186.2M"[Angie Park]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Sep 24, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Sep 25, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Nov 8, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Dec 25, 2026EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the ACN earnings preview cover?

This Accenture plc (ACN) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in ACN earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.

Where do the numbers on this page come from?

Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.

Is this a buy or sell recommendation?

No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.

More earnings, decoded